INVO Fertility, Inc.

INVO Fertility, Inc. is dedicated to providing innovative fertility solutions, focusing on developing and commercializing technologies that enhance the accessibility and effectiveness of fertility treatments for individuals and couples experiencing infertility.

CCI Score

30.62

-0.13% May 31

Latest Event

INVO Fertility Rebrands, Aligns with Progressive IVF Access

INVO Fertility, formerly NAYA Biosciences, has rebranded with a name and ticker symbol change to IVF as it restructures to focus on expanding its network of fertility clinics. The CEO cited the U.S. President’s recent executive order aimed at reducing IVF costs and expanding access, suggesting alignment with progressive, inclusive healthcare policies.

Take Action

So what can you do? Support by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: OneOncology

Seidman Cancer Center

CCRM
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

DISSENTER

INVO Fertility, Inc. is currently rated as a Dissenter.

+25 to +44 CCI Score

These companies are vocal in their opposition to authoritarian regimes. They publicly criticize oppressive policies and engage in advocacy efforts to promote accountability and transparency, even if their actions aren’t as extensive as those of Moral Leaders.

Latest Events

APR

28

2025

INVO Fertility Rebrands, Aligns with Progressive IVF Access
30.62

INVO Fertility, formerly NAYA Biosciences, has rebranded with a name and ticker symbol change to IVF as it restructures to focus on expanding its network of fertility clinics. The CEO cited the U.S. President’s recent executive order aimed at reducing IVF costs and expanding access, suggesting alignment with progressive, inclusive healthcare policies.
+40

Public and Political Behavior

April 30

The company’s CEO explicitly referenced the U.S. President’s executive order on reducing IVF costs and expanding access as a validation for the market opportunity. This public comment ties the firm’s rebranding to supportive progressive policies that aim to improve healthcare accessibility for marginalized groups.

Sarasota fertility company changes name, ticker symbol
+20

Business Practices and Ethical Responsibility

April 30

The restructuring and rebranding signal a strategic shift to focus on expanding fertility clinics and operational centers across the U.S., which promotes better access to essential fertility services. This business decision aligns with policies aimed at increasing accessibility and supporting community health.

Sarasota fertility company changes name, ticker symbol